Fundraising Fox

Scott Brun

Investor

Venture Partner at Abingworth

Chicago, Illinois

Writes $15M – $30M checks · typically $22.5M

About

Scott Brun has over twenty years of experience in the pharmaceutical industry. He previously served as AbbVie's VP of Scientific Affairs and Head of AbbVie Ventures, where the ventures group grew to include more than 20 active companies, and earlier held roles as VP and Head of Pharmaceutical Development at AbbVie and drug development positions at Abbott Laboratories. He holds an MD from Johns Hopkins University School of Medicine and completed a residency in Ophthalmology at Harvard Medical School.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Gold Mast Consulting, LLCPresidentcurrent2019 — presentGreater Chicago Area
  2. AbbVieVP, Corporate Strategy Office, Scientific Affairs and Head, AbbVie Ventures2016 — 2019North Chicago, IL
  3. AbbVieVice President, Pharmaceutical Development2012 — 2016North Chicago IL
  4. AbbottDivisional Vice President, Infectious Disease Development2009 — 2012North Chciago IL
  5. AbbottDivisional Vice President, Infectious Disease and Immunology Development2008 — 2009North Chicago, IL
  6. AbbottDivisional Vice President, Infectious Disease and Renal Development2006 — 2008North Chicago, IL
  7. AbbottDivisional Vice President , Infectious Disease Development2004 — 2006
  8. AbbottGlobal Project Head, Global Medical Director, Antiviral Global Project Team2002 — 2004North Chicago, IL

Education

  1. Massachusetts Eye and Ear Infirmary, Harvard Medical SchoolResidency in Ophthalmology1994 — 1997
  2. The Johns Hopkins University School of MedicineDoctor of Medicine1989 — 1993
  3. University of Illinois Urbana-ChampaignBachelor of Science (B.S.), Biochemistry1985 — 1989

Same school

Also attended The Johns Hopkins University School of Medicine25

Hal PazInvestor at Khosla VenturesBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture FundGreg HornerInvestor at Sand Hill Angels

+ 19 more

Also attended University of Illinois Urbana-Champaign259

Sundeep PeechuGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystPrashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesPaul BragielCo-founder at Golden Gate VenturesGreg RudinBoard Partner at Menlo Ventures

+ 253 more

Shared employers

Also worked at AbbVie36

Nick GasbarroChief of Staff at QED InvestorsJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next VenturesAndrew BierDigital Pharma Advisor at Excelerate Health VenturesShwen GweeDigital Pharma Advisor at Excelerate Health VenturesMelissa LokugamageSenior Venture Associate at 82VS

+ 30 more

Also worked at Abbott51

Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalCharles BeyrouthyFounder & Managing Partner at Forma PrimeFederico RaneroVenture Partner at NazcaJennifer SmoterChief Communications & Governance Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda Ventures

+ 45 more

Investments

Board seats

Axial TherapeuticsHorizon

Per the firm's website.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth